Literature DB >> 9114904

A comparison in young and elderly subjects of the pharmacokinetics and pharmacodynamics of single and multiple doses of benazepril.

N J Macdonald1, H L Elliott, D M Hughes, J L Reid.   

Abstract

1. The pharmacokinetics and pharmacodynamics of single and multiple oral doses of the ACE inhibitor benazepril were investigated in young and elderly normotensive subjects. 2. Following multiple doses the trough concentrations were significantly higher in the elderly and the areas under the plasma concentration-time curves (AUC0-24) were significantly greater, by approximately 23%. 3. The fall in blood pressure tended to be greater in the elderly subjects but this is likely to be attributable to their higher initial blood pressures, although it may reflect the small differences in pharmacokinetics. 4. The age related differences in kinetics and dynamics following multiple dosing are quantitatively similar to those obtained with single doses. However, there appears to be a quantitative difference between benazepril and other ACE inhibitors in that the age related increases were of a relatively smaller magnitude.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 9114904      PMCID: PMC1364638          DOI: 10.1111/j.1365-2125.1993.tb04217.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  A liquid chromatography-assisted assay for angiotensin-converting enzyme (peptidyl dipeptidase) in serum.

Authors:  S G Chiknas
Journal:  Clin Chem       Date:  1979-07       Impact factor: 8.327

2.  The effects of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalapril.

Authors:  N J Macdonald; A Sioufi; C A Howie; J R Wade; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1993-09       Impact factor: 4.335

3.  Determination of benazepril, a new angiotensin-converting enzyme inhibitor, and its active metabolite, benazeprilat, in plasma and urine by capillary gas chromatography-mass-selective detection.

Authors:  A Sioufi; F Pommier; G Kaiser; J P Dubois
Journal:  J Chromatogr       Date:  1988-12-29

4.  Concentrations of angiotensin-converting enzyme in tissues of the rat.

Authors:  D W Cushman; H S Cheung
Journal:  Biochim Biophys Acta       Date:  1971-10

5.  Effect on blood pressure and the renin-angiotensin system of repeated doses of the converting enzyme inhibitor CGS 14824A.

Authors:  G Waeber; T Fasanella d'Amore; J Nussberger; B Waeber; H R Brunner
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteers.

Authors:  M D Schaller; J Nussberger; B Waeber; J P Bussien; G A Turini; H Brunner; H R Brunner
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Age and the pharmacokinetics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.

Authors:  N Hockings; A A Ajayi; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

8.  Influence of age on the pharmacokinetics and pharmacodynamics of perindopril.

Authors:  K R Lees; S T Green; J L Reid
Journal:  Clin Pharmacol Ther       Date:  1988-10       Impact factor: 6.875

9.  Pharmacokinetics and pharmacodynamics of the ace inhibitor benazepril hydrochloride in the elderly.

Authors:  G Kaiser; R Ackermann; W Dieterle; C J Durnin; J McEwen; K Ghose; A Richens; I B Holmes
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 10.  Angiotensin-converting enzyme inhibitors in the elderly.

Authors:  J L Reid; N J Macdonald; K R Lees; H L Elliott
Journal:  Am Heart J       Date:  1989-03       Impact factor: 4.749

View more
  1 in total

Review 1.  Optimal dosage of ACE inhibitors in older patients.

Authors:  B Tomlinson
Journal:  Drugs Aging       Date:  1996-10       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.